RAS and BRAF Wild-type
1 clinical trials · Condition
◉ Watch RAS and BRAF Wild-type
| Record | Firm | Date |
|---|---|---|
| Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients (NCT04080843) | Zhejiang University | 2019-11-15 |
Track RAS and BRAF Wild-type automatically
Every clearance here is in the API, with alerts when new ones post.